The WHO Regional Committee for Europe approved a new action plan to tackle multi-drug resistant and extensively drug resistant tuberculosis (M/XDR-TB) today. This is another milestone in the European efforts to secure strong tuberculosis prevention and control across the region.
The second ECDC advisory group meeting will discuss progress and future challenges in reporting and monitoring following the commitment outlined in the Dublin Declaration.
Starting 15 September 2011, ECDC will be coordinating the former EUVAC.NET network. It is a surveillance network covering measles, mumps, rubella, congenital rubella, pertussis and varicella EU Member States and three countries of the European Economic Area. Data will be hosted by the European Surveillance System (TESSy) at ECDC.
The Centre for Infectious Disease Control (CIb) of the Dutch National Institute for Public Health and the Environment (RIVM) has compiled a chronological overview of that country’s response to the 2009 influenza A(H1N1) pandemic.
This paper and review from a Singapore-based group compared results obtained for estimating rates of new infections during the 2009 pandemic. They derived rates from paired specimens from the same patient (serum cohort approach), cross-sectional serological surveys, rates of unconfirmed syndromic influenza-like-illness (ILI) obtained from primary care physicians in sentinel general practices, and combined clinical repos with laboratory confirmed samples.
This collection of article is intended to clarify the issues that arose, during the 2009 pandemic around definitions of the pandemic term, both in a theoretical and practical way.